Wun‐Ching Yu

1.3k total citations
7 papers, 1.1k citations indexed

About

Wun‐Ching Yu is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Wun‐Ching Yu has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hepatology and 2 papers in Oncology. Recurrent topics in Wun‐Ching Yu's work include Angiogenesis and VEGF in Cancer (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (2 papers). Wun‐Ching Yu is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease and Transplantation (2 papers). Wun‐Ching Yu collaborates with scholars based in Hong Kong, China and Germany. Wun‐Ching Yu's co-authors include Ronnie Tung‐Ping Poon, Cecilia Lau, Irene Oi‐Lin Ng, John Wong, C.M. Lo, S T Fan, Kwan Man, H Lau, J Wong and ST Cheung and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and British journal of surgery.

In The Last Decade

Wun‐Ching Yu

7 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wun‐Ching Yu Hong Kong 7 586 398 284 283 235 7 1.1k
Cecilia Lau Hong Kong 12 672 1.1× 692 1.7× 495 1.7× 157 0.6× 391 1.7× 14 1.5k
Tong‐Chun Xue China 22 405 0.7× 466 1.2× 321 1.1× 208 0.7× 501 2.1× 41 1.3k
Hien Dang United States 15 373 0.6× 479 1.2× 268 0.9× 157 0.6× 376 1.6× 24 1.0k
Renan Jin China 17 258 0.4× 703 1.8× 463 1.6× 156 0.6× 274 1.2× 34 1.2k
Joanna W. Ho Hong Kong 15 346 0.6× 638 1.6× 281 1.0× 113 0.4× 283 1.2× 16 1.1k
Laia Cabellos Spain 9 464 0.8× 721 1.8× 514 1.8× 217 0.8× 235 1.0× 19 1.3k
M Furutani Japan 11 236 0.4× 593 1.5× 378 1.3× 83 0.3× 354 1.5× 16 979
Nigel C. Bird United Kingdom 17 266 0.5× 373 0.9× 257 0.9× 100 0.4× 467 2.0× 28 1.1k
Ling–Qun Kong China 19 232 0.4× 586 1.5× 411 1.4× 116 0.4× 448 1.9× 23 1.3k
Alexander Huether Germany 11 200 0.3× 431 1.1× 166 0.6× 151 0.5× 344 1.5× 12 903

Countries citing papers authored by Wun‐Ching Yu

Since Specialization
Citations

This map shows the geographic impact of Wun‐Ching Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wun‐Ching Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wun‐Ching Yu more than expected).

Fields of papers citing papers by Wun‐Ching Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wun‐Ching Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wun‐Ching Yu. The network helps show where Wun‐Ching Yu may publish in the future.

Co-authorship network of co-authors of Wun‐Ching Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wun‐Ching Yu. A scholar is included among the top collaborators of Wun‐Ching Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wun‐Ching Yu. Wun‐Ching Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ren, Yi, Ronnie Tung‐Ping Poon, Irene Oi‐Lin Ng, et al.. (2003). Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. International Journal of Cancer. 107(1). 22–29. 118 indexed citations
2.
Ren, Yi, Ronnie Tung‐Ping Poon, Wenhong Chen, et al.. (2003). Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.. PubMed. 9(16 Pt 1). 5996–6001. 161 indexed citations
3.
Poon, Ronnie Tung‐Ping, et al.. (2003). Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.. PubMed. 63(12). 3121–6. 173 indexed citations
4.
Poon, Ronnie Tung‐Ping, Irene Oi‐Lin Ng, Cecilia Lau, et al.. (2002). Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study. Journal of Clinical Oncology. 20(7). 1775–1785. 240 indexed citations
5.
Poon, Ronnie Tung‐Ping, et al.. (2001). Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. The American Journal of Surgery. 182(3). 298–304. 113 indexed citations
6.
Lau, H, Kwan Man, S T Fan, et al.. (1997). Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. British journal of surgery. 84(9). 1255–1259. 264 indexed citations
7.
Lau, H, Kwan Man, S T Fan, et al.. (1997). Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. British journal of surgery. 84(9). 1255–1259. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026